Type 1 Diabetes Drugs 2018-2024 Global Market Outlook by Type, End-User and Region - ResearchAndMarkets.com

DUBLIN--()--The "Type 1 Diabetes Drugs Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024" report has been added to ResearchAndMarkets.com's offering.

The report predicts the global type 1 diabetes drugs market to grow with a CAGR of 7.4% over the forecast period of 2018-2024.

Growing occurrence of type 1 diabetes is the major factor driving the type 1 diabetes drugs market. The rising awareness about the type 1 diabetes and availability of its treatment drugs, introduction of new advanced insulin delivery devices such as pumps & pens and improved drug delivery system is expected to boost the growth of the type 1 diabetes drug market over the forecast period.

However, high cost of insulin delivery systems, especially insulin pump and auto injector may act as a restraint to market growth. Moreover, the ongoing innovations in the diabetes drugs and the drug delivery system are projected to create the several opportunities in upcoming years.

Among regions, North America is dominating the type 1 diabetes drugs market owing to the high occurrence of diabetes among the population and adoption of new innovative insulin delivery systems such as insulin pumps are the major factors that are driving the North America region.

The rapidly growing aging population and improved healthcare infrastructure in the Asia pacific region is likely to help to grow Asia Pacific region at the highest CAGR, during the forecast period

Key Topics Covered

1. Preface

2. Executive Summary

3. Global Type 1 Diabetes Drugs Market Overview

4. Global Type 1 Diabetes Drugs Market by Type

5. Global Type 1 Diabetes Drugs Market by End-User

6. Global Type 1 Diabetes Drugs Market by Region 2018-2024

7. Companies Covered

  • Eli Lilly and Company
  • Novo Nordisk A/S
  • XOMA Corp.
  • Biodel, Inc.
  • B.Braun Melsungen AG
  • Astrazeneca Plc.
  • DiaVacs, Inc.
  • Biodel, Inc.
  • Macrogenics, Inc.

For more information about this report visit https://www.researchandmarkets.com/research/gwbcfw/type_1_diabetes?w=4

Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Endocrine and Metabolic Disorders Drugs

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Endocrine and Metabolic Disorders Drugs